< Annex III: Essential-use authorizations for 2007 and 2008 of chlorofluorocarbons for metered-dose inhalers approved by the Eighteenth Meeting of the Parties Up one level Decision XVII/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol > Seventeenth Meeting of the Parties Decision XVII/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol Decision XVII/2: Request by Cyprus to be removed from the list of developing countries under the Montreal Protocol Decision XVII/3: Application to Belgium, Poland and Portugal of paragraph 8 of Article 4 of the Montreal Protocol with respect to the Beijing Amendment to the Montreal Protocol Decision XVII/4: Application to Tajikistan of paragraph 8 of Article 4 of the Montreal Protocol with respect to the Beijing Amendment to the Montreal Protocol Decision XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007 Decision XVII/6: Process agents Decision XVII/7: List of uses of controlled substances as process agents Decision XVII/8: List of uses of controlled substances as process agents Decision XVII/9: Critical-use exemptions for methyl bromide for 2006 and 2007 Decision XVII/10: Laboratory and analytical critical uses of methyl bromide Decision XVII/11: Recapturing/recycling and destruction of methyl bromide from space fumigation Decision XVII/12: Minimizing production of chlorofluorocarbons by Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol to meet the basic domestic needs of Parties operating under paragraph 1 of Article 5 Decision XVII/13: Use of carbon tetrachloride for laboratory and analytical uses in Parties operating under paragraph 1 of Article 5 of the Montreal Protocol Decision XVII/14: Difficulties faced by some Parties operating under paragraph 1 of Article 5 of the Montreal Protocol with respect to chlorofluorocarbons used in the manufacture of metered-dose inhalers Decision XVII/15: Coordination between the Ozone Secretariat and the Secretariat of the International Plant Protection Convention Decision XVII/16: Preventing illegal trade in controlled ozone-depleting substances Decision XVII/17: Technical and financial implications of the environmentally sound destruction of concentrated and diluted sources of ozone-depleting substances Decision XVII/18: Request for assistance of the Technology and Economic Assessment Panel for the meeting of experts on destruction Decision XVII/19: Consideration of the Technology and Economic Assessment Panel and Intergovernmental Panel on Climate Change assessment report as it relates to actions to address ozone depletion Decision XVII/20: Data and information provided by the Parties in accordance with Article 7 of the Montreal Protocol Decision XVII/21: Non-compliance with data-reporting requirements under Articles 5 and 7 of the Montreal Protocol by Parties recently ratifying the Montreal Protocol Decision XVII/22: Non-compliance with data-reporting requirements for the purpose of establishing baselines under Article 5, paragraphs 3 and 8 ter (d) Decision XVII/23: Report on the establishment of licensing systems under Article 4B of the Montreal Protocol Decision XVII/24: Reports of the Parties submitted under Article 9 of the Montreal Protocol on research, development, public awareness and exchange of information Decision XVII/25: Non-compliance with the Montreal Protocol by Armenia and request for a plan of action Decision XVII/26: Non-compliance with the Montreal Protocol by Azerbaijan Decision XVII/27: Non-compliance with the Montreal Protocol by Bangladesh Decision XVII/28: Non-compliance with the Montreal Protocol by Bosnia and Herzegovina Decision XVII/29: Non-compliance with the Montreal Protocol by Chile Decision XVII/30: Potential non-compliance in 2004 with consumption of the controlled substances in Annex B group I (other fully halogenated chlorofluorocarbons) by China, and request for a plan of action Decision XVII/31: Non-compliance with the Montreal Protocol by Ecuador Decision XVII/32: Non-compliance with the Montreal Protocol by Federated States of Micronesia Decision XVII/33: Non-compliance with the Montreal Protocol by Fiji Decision XVII/34: Revised plan of action to return Honduras to compliance with the control measures in Article 2H of the Montreal Protocol Decision XVII/35: Potential non-compliance in 2004 with the controlled substances in Annex A, group I (CFCs) by Kazakhstan, and request for a plan of action Decision XVII/36: Non-compliance with the Montreal Protocol by Kyrgyzstan Decision XVII/37: Non-compliance with the Montreal Protocol by the Libyan Arab Jamahiriya Decision XVII/38: Non-compliance with the Montreal Protocol by Sierra Leone, and request for a plan of action Decision XVII/39: Revised plan of action for the early phase-out of methyl bromide in Uruguay Decision XVII/40: The 2006-2008 replenishment of the Multilateral Fund Decision XVII/41: Fixed-exchange-rate mechanism for the replenishment of the Multilateral Fund Decision XVII/42: Financial matters: Financial reports and budgets Decision XVII/43: Membership of the Implementation Committee Decision XVII/44: Membership of the Executive Committee of the Multilateral Fund Decision XVII/45: Endorsement of new co-chairs of the technical options committees of the Technology and Economic Assessment Panel Decision XVII/46: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol Decision XVII/47: Dates of future Montreal Protocol meetings Decision XVII/48: Eighteenth Meeting of the Parties to the Montreal Protocol Annex I: Trust fund for the Vienna Convention for the Protection of the Ozone Layer: revised approved 2005 and approved Annex II: Trust fund for the Vienna Convention: scale of contributions for 2006, 2007 and 2008 Annex III: Contributions by Parties to the sixth replenishment of the Multilateral Fund (2006, 2007 and 2008) Annex IV: Trust Fund for the Montreal Protocol on Substances that Deplete the Ozone Layer: revised approved 2005 and approved 2006 and 2007 budgets Annex V: Trust Fund for the Montreal Protocol: scale of contributions for 2006 and 2007 < Annex III: Essential-use authorizations for 2007 and 2008 of chlorofluorocarbons for metered-dose inhalers approved by the Eighteenth Meeting of the Parties Up one level Decision XVII/1: Status of ratification of the Vienna Convention, the Montreal Protocol and the London, Copenhagen, Montreal and Beijing amendments to the Montreal Protocol >
